AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2022
Nov 16, 2022
32106_dirs_2022-11-15_4ff0b93c-4010-4c19-97f4-09b936285538.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2022-11-14
Reporting Person: DE GREEF RODERICK (COO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-14 | Common Stock | S | 14000 | $23.57 | Disposed | 102719 | Direct |
| 2022-11-14 | Common Stock | S | 6000 | $24.53 | Disposed | 96719 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.09 to $24.07, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.15 to $24.94, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.